A consumer-focused examination of NAD+ injections, NAD+ supplements, NAD+ peptides, NAD+ dosage protocols, documented NAD+ benefits, and potential NAD+ side effects ...

This article was reviewed by Lynn Marie Morski, MD, JD Key Takeaways: Peptides are compounds made of amino acids linked by ...

New nanomaterial passes the blood-brain barrier to reduce damaging inflammation after the most common form of stroke. When ...

US biotech firm Fractyl Health is developing Rejuva, an experimental gene therapy that may mimic GLP-1 drugs for years after ...

Recent GLP-1 (glucagon-like peptide-1) obesity treatments such as ‘Wegovy’ and ‘Mounjaro’ have gained immense popularity, but ...

Sun Pharmaceutical Industries announced that it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection.

Sun Pharma receives DCGI approval to launch generic semaglutide injection, Noveltreat, for weight management in India.

The company has received approval from the Drugs Controller General of India (DCGI) to manufacture and market Semaglutide ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated for weight management as an adjunct to a reduced-calorie diet and increased physical activity.

GoodRx reports transitioning from injectable to oral GLP-1s can simplify weight loss routines, but requires careful timing and consistency.

Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due ...

Results of the SPACE trial demonstrating the safety and efficacy of subcutaneous fremanezumab for the prevention of pediatric ...